A prospective clinical study to compare the clinical performance of the FINDER™ Instrument and the G6PD assay to an FDA cleared instrument/reagent combination in adult and neonate populations.

A prospective clinical study to compare the clinical performance of the FINDER™ Instrument and the G6PD assay to an FDA cleared instrument/reagent combination in adult and neonate populations. Neonate and adult subjects will be recruited from 3 clinical sites. Neonate samples will be collected as heel prick unless an in dwelling line is already in place at which point a venous or arterial/umbilical sample will be collected. Adult samples will be collected as venous/arterial samples and finger stick samples. Samples will be tested at the point of care/near patient and in the clinical laboratory using the FINDER Instrument and G6PD assay on a digital microfluidic platform. Samples will also be sent to a third party CLIA laboratory for test using an FDA 510(k) cleared instrument/reagent combination for G6PD.

Inclusion Criteria:

• Neonates aged >35 gestational weeks or older.
• Adult subjects who are age 18 and older.
• Adult subjects who weigh at least 110 pounds.
• All ethnicities.
• Male and female subjects.

Exclusion Criteria:

• Adult subjects who weigh less than 110 pounds.
• Subjects with anemia for which an attending physician will not authorize a blood draw.
• Subjects who have received a blood transfusion.
• Subjects who are pregnant.

Adults who are at least 18 years of age or older. Neonates who are at least 35 gestational weeks old, recruited from the well baby nursery or the NICU.